Electra Therapeutics Targets Nearly $978 Million Valuation in Nasdaq IPO
Electra plans to offer about 21.67 million shares at $14 to $16 each, seeking up to roughly $346.7 million in gross proceeds and a Nasdaq listing under ETRA.
Electra plans to offer about 21.67 million shares at $14 to $16 each, seeking up to roughly $346.7 million in gross proceeds and a Nasdaq listing under ETRA.
Corteva shareholders of record on September 24 are expected to receive one Vylor share for every Corteva share, with the distribution set for October 1.
The partners' first project is a more than 22 MW carrier-neutral campus in Ankara, where early construction has started ahead of a planned 2028 completion.
Baldwin shareholders will receive $32.50 a share in cash, while the $7.7 billion enterprise value includes about $3.1 billion of net debt.
Rainier Acquisition unit holders can elect to separate RNAQU units starting Sept. 14, with the resulting RNAQ shares and RNAQW warrants scheduled to begin trading on Nasdaq Sept.…
NUBURU’s shares return under the BURU symbol after a 1-for-40 reverse split addressed the low-price issue behind NYSE American’s July trading suspension.
The bridge starts with a $2.5 million advance, carries no interest before closing and is cancelled if Onconetix completes its pending acquisition of Realbotix LLC.
Updated PRESERVE-003 data showed median overall survival of 18.5 months with gotistobart versus 10.0 months with docetaxel; the pivotal stage remains ongoing.
The Federal Reserve notice sets an October 14 comment deadline and outlines TabaPay's planned bank holding company structure and related activities.
Vend purchased 328,000 shares from September 7 to 11, taking spending in the second tranche of its current buyback programme to NOK 513.6 million.